Collectively, these results indicated that the presence of GCC2 on the surface of the exosomes could be a predictive marker for lung cancer diagnosis, suggesting that GCC2 could be a potential biomarker for NSCLC. Here, GCC2 is linked to non-small cell lung carcinoma.